Keywords: pharmacoeconomic, data, gusto, supports, tpa, thrombolysis, acute

Pharmacoeconomic Data From GUSTO Supports tPA

Article | 05 June 1995

Thrombolysis in acute myocardial infarction patients using Genentech's tissue plasminogen activator product Activase (alteplase) costs more than using streptokinase, but ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genentech

Go to company listing

Related Drugs

Activase

Alteplase

Streptase

Streptokinase

Go to drug listing